Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies
Nicola Lawson(AstraZeneca (United Kingdom)), Craig Barker(AstraZeneca (United Kingdom))
Cited by 87
Related Papers
No related papers found
Powered by citation graph analysis